ADGRL3 and attention deficit-hyperactivity disorder: Single-nucleotide polymorphisms in ADGRL3 that result in haploinsufficiency have been associated with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and are predictive of susceptibility to substance use disorders (1, 2).